New York, NY, June 26, 2009 --(PR.com
)-- Vascular Health Specialists (VHS), a firm dedicated to leveraging the latest dermatologic research to develop cutting-edge products for rosacea and other skin conditions, is pleased to announce the addition of Dr. Patrick Bitter, Sr. to the firm.
Dr. Bitter, Sr. brings a wealth of experience in treating inflammatory skin disorders and a passion for anti-aging medicine to Vascular Health Specialists. Dr. Bitter, a dermatologist who has been actively practicing in San Francisco for over 30 years, has always been at the forefront of dermatologic advances, particularly in the field of rosacea treatment. In 1998, Dr. Bitter, Sr., introduced the PhotoFacialSM procedure. This treatment, also known today as Intense Pulsed Light or IPL PhotoRejuvenation, is now performed around the globe and is considered one of the most effective treatments for rosacea. In fact, Dr. Bitter, Sr. has personally treated thousands of rosacea sufferers with the PhotoFacialSM procedure.
Dr. Bitter, Sr. brings this same pioneering spirit to his role at Vascular Health Specialists LLC. Over the last several months, he has been instrumental in the pre-launch evaluation of RosadynTM, VHS’s flagship product, an oral nutraceutical that targets facial flushing, redness, and inflammation caused by rosacea. Dr. Bitter, Sr. explains, "This is one of the most exciting new treatment products for rosacea sufferers. This should help many rosacea sufferers as it targets the main pathophysiology behind rosacea.” According to Dr. Geoffrey Nase, PhD, VHS’s founder and developer of RosadynTM, “Dr. Bitter brings invaluable clinical treatment expertise of rosacea and a true passion for the development of novel skin treatments to VHS. We have already seen the benefit of his involvement in the final stages of RosadynTM development and we are incredibly excited about cosmeceutical formulations he is already researching.”
Going forward, the two will spearhead Vascular Health Specialists’ future product pipeline. Dr. Bitter, Sr. explains, “We have already started development of some novel formulations for a topical preparation for rosacea. While our main focus is on treating the underserved rosacea population, many of the ingredients we have found effective for rosacea treatment can be leveraged more broadly for skin rejuvenation and anti-aging medicine for hyper-sensitive skin. These areas will be a focus for future research and product development.”
RosadynTM is scheduled for release on July 1st, 2009.
About Vascular Health Specialists:
Vascular Health Specialists (VHS) is a firm dedicated to leveraging the latest dermatologic research to develop cutting edge products for rosacea and other skin conditions. Comprised of a team of professionals with backgrounds in medicine, research, business and skin care product development, VHS works closely with leading laboratories and nutraceutical manufacturers to remain at the forefront of novel skin treatments.
For more information, please visit the company website at: http://www.rosadyn.com